4.03
0.75%
+0.03
After Hours:
4.08
0.05
+1.24%
Applied Dna Sciences Inc stock is currently priced at $4.03, with a 24-hour trading volume of 49,680.
It has seen a +0.75% increased in the last 24 hours and a +859.52% rose in the past month.
The chart indicates a potential bullish trend, as the stock is above the $3.90 pivot point. If it approaches the $4.19 resistance level, significant changes may occur.
Previous Close:
$4.00
Open:
$3.94
24h Volume:
49,680
Market Cap:
$3.48M
Revenue:
$9.00M
Net Income/Loss:
$-7.21M
P/E Ratio:
-8.3958
EPS:
-0.48
Net Cash Flow:
$-7.59M
1W Performance:
+1,588%
1M Performance:
+859.52%
6M Performance:
+434.13%
1Y Performance:
+305.19%
Applied Dna Sciences Inc Stock (APDN) Company Profile
Name
Applied Dna Sciences Inc
Sector
Industry
Phone
631 240 8800
Address
50 Health Sciences Drive, Stony Brook, NY
Applied Dna Sciences Inc Stock (APDN) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Feb-12-21 | Initiated | ROTH Capital | Buy |
Jan-14-21 | Reiterated | H.C. Wainwright | Buy |
Dec-18-20 | Reiterated | H.C. Wainwright | Buy |
Jul-20-20 | Reiterated | H.C. Wainwright | Buy |
Jul-02-20 | Initiated | H.C. Wainwright | Buy |
Nov-14-16 | Reiterated | Maxim Group | Buy |
May-13-16 | Reiterated | Maxim Group | Buy |
Oct-08-15 | Reiterated | Maxim Group | Buy |
May-26-15 | Initiated | The Benchmark Company | Speculative Buy |
Feb-10-15 | Reiterated | Maxim Group | Buy |
Jan-13-15 | Initiated | Maxim Group | Buy |
View All
Applied Dna Sciences Inc Stock (APDN) Latest News
Allegion (ALLE) Q1 Earnings Surpass Estimates
Zacks Investment Research
Is Applied DNA Sciences (APDN) Outperforming Other Industrial Products Stocks This Year?
Zacks Investment Research
Applied DNA Sciences (APDN) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research
Lululemon To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Friday
Benzinga
Applied Dna Sciences Inc Stock (APDN) Financials Data
Applied Dna Sciences Inc (APDN) Revenue 2024
APDN reported a revenue (TTM) of $9.00 million for the quarter ending December 31, 2023, a -53.31% decline year-over-year.
Applied Dna Sciences Inc (APDN) Net Income 2024
APDN net income (TTM) was -$7.21 million for the quarter ending December 31, 2023, a +2.45% increase year-over-year.
Applied Dna Sciences Inc (APDN) Cash Flow 2024
APDN recorded a free cash flow (TTM) of -$7.59 million for the quarter ending December 31, 2023, a +5.60% increase year-over-year.
Applied Dna Sciences Inc (APDN) Earnings per Share 2024
APDN earnings per share (TTM) was -$0.55 for the quarter ending December 31, 2023, a +15.38% growth year-over-year.
About Applied Dna Sciences Inc
Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. The company operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-based therapeutics. The MDx Testing Services segment provides clinical molecular diagnostics (MDx) testing and clinical laboratory testing services; COVID-19 testing services, including test scheduling, sample collection, and automated results reporting for higher education institutions, private clients, and businesses under the safeCircle trademark; polymerase chain reaction (PCR)-based MDx testing services for the Monkeypox virus; and MDx test kits and related supplies, as well as validates pharmacogenetics (PGx) testing services. The DNA Tagging and Security Products and Services segment offers SigNature Molecular Tags, which provides a methodology to authenticate goods within large and complex supply chains for materials, such as cotton, leather, pharmaceuticals, nutraceuticals, and other products; SigNify IF portable DNA readers and SigNify consumable reagent test kits, which offers a front-line solution for supply chain integrity backed with forensic-level molecular tag authentication; and fiberTyping, which uses PCR-based DNA detection to detect a product's naturally occurring DNA sequences for the purposes of product provenance authentication and supply chain security. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.
Cap:
|
Volume (24h):